Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FossiLabs was a private U.S. medical device company focused on engineering 3D-printed porous polyether ether ketone (PEEK) structures for implantable spinal devices. The company developed a proprietary additive manufacturing process designed to create fully interconnected porous, bone-like scaffolds with enhanced hydrophilicity to improve osseointegration and implant performance. Its technology was aimed primarily at interbody fusion implants and related spine applications rather than a drug pipeline. FossiLabs was acquired by Curiteva in December 2020, and its technology became part of Curiteva's commercial porous PEEK spine implant platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FossiLabs.